1579PPrognostic factors for non-small cell lung cancer patients with driver mutation negative and brain metastases (HOT 1701)

ConclusionsPrognosis of NSCLC patients with EGFR, ALK negative and BM is poor. In addition to the known prognostic factors such as DS-GPA, this study shown that male, T factor, N factor, and histological type of non-adenocarcinoma, had a prognostic role in NSCLC patients with driver mutation negative and BM.Clinical trial identificationUMIN000030313, 08/12/2017.Legal entity responsible for the studyHokkaido Lung Cancer Clinical Study Group Trial: HOT.FundingHas not received any funding.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research